Cliniphar Ltd. (TYO:432A)

Cliniphar Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024
Period Ending	Mar 31, 2025	Mar 31, 2024
Cash & Equivalents	1,142	1,193
Cash & Short-Term Investments	1,142	1,193
Cash Growth	-4.28%	-
Receivables	131	105
Inventory	289	187
Other Current Assets	64	67
Total Current Assets	1,626	1,552
Property, Plant & Equipment	32	17
Long-Term Investments	881	575
Other Intangible Assets	75	89
Long-Term Deferred Tax Assets	45	45
Other Long-Term Assets	3	1
Total Assets	2,662	2,279
Accounts Payable	16	11
Short-Term Debt	100	100
Current Portion of Long-Term Debt	379	101
Current Income Taxes Payable	7	-
Other Current Liabilities	93	61
Total Current Liabilities	595	273
Long-Term Debt	936	1,020
Long-Term Leases	-	1
Other Long-Term Liabilities	115	117
Total Liabilities	1,646	1,411
Common Stock	10	10
Additional Paid-In Capital	6	6
Retained Earnings	1,068	878
Comprehensive Income & Other	-68	-26
Shareholders' Equity	1,016	868
Total Liabilities & Equity	2,662	2,279
Total Debt	1,415	1,222
Net Cash (Debt)	-273	-29
Net Cash Per Share	-273.00	-29.00
Filing Date Shares Outstanding	1	1
Total Common Shares Outstanding	1	1
Working Capital	1,031	1,279
Book Value Per Share	1016.00	868.00
Tangible Book Value	941	779
Tangible Book Value Per Share	941.00	779.00

Source: S&P Global Market Intelligence. Standard template. Financial Sources.